Collectively, our data suggest that the miR-221-3p/222-3p cluster could potentially regulate AT functionality through the modulation of DVL2, ETS1, and IL1RAP during obesity and T2D. This evidence concerns the gene DVL2 and type 2 diabetes mellitus.